The penultimate step in the anthocyanin biosynthetic pathway (Extended Data Fig
PMID: 20360006
Looking for Market Leaders Only two companies, Eli Lilly and Novo Nordisk, have sizable GLP-1s available today, and we expect them to dominate the market over the intermediate term
Additionally, if youre looking to avoid getting pregnant, these drugs may affect how well your birth control works
Duality of interest JJM has participated on advisory boards or has been invited as speaker by Astra Zeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly & Co., Intarcia Therapeutics Inc., MSD, Novo Nordisk, Novartis and Sanofi
On boosting the drug, the honest answer is that it is an interesting possibility rather than a proven effect